{"pageContent": "Purpose: Recent evidence indicates that small noncoding RNA molecules, known as microRNAs (miRNAs), are involved in cancer initiation and progression. We hypothesized that genetic variations in miRNAs and miRNA target sites could be associated with the efficacy of androgen-deprivation therapy (ADT) in men with prostate cancer.", "metaData": {"source": "The Prostate Cancer Outcomes (PCO) study in prostate cancer centres certified by the German Cancer Society\nhttps://pubmed.ncbi.nlm.nih.gov/32548712/"}}